NY-EMPIRE-STATE-REALTY
21.11.2023 20:59:26 CET | Business Wire | Press release
The Empire State Building (ESB) today announced the details of its annual holiday festivities. Celebrations through the end of the year will include seasonal holiday décor, visits from Santa Claus, pop ups, and special tower lightings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121955174/en/
Most Wonderful Time of the Year: Empire State Building Announces Fan-Favorite Holiday Programs to Include 20th Anniversary Elf Activations, Classic Holiday Décor, Festive Pop-Ups, Special Lightings and More (Photo: Business Wire)
“The holiday season is upon us, and we are excited to provide our guests with one-of-a-kind, holiday-themed experiences here at the Empire State Building,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This year’s visitors are in for lots of treats -- from photos with Santa to elaborate holiday decorative displays and dedications to the Empire State Building’s co-star, ‘Elf,’ to celebrate the film’s 20th anniversary.”
Deck the Halls
Ornaments, wreaths, tinsel, and bows with silver and gold accents adorn the entire Observatory Experience with a large, bright menorah in front of the two-story building model. Inspired by Santa’s workshop, guests can take their holiday photos on the Empire State Building’s 80th Floor in a snowy corner display with Christmas trees, wrapped presents, a cozy fireplace backdrop, and Santa’s oversized chair.
The building’s landmark Fifth Avenue Lobby, that can be visited after conclusion of guests’ visits to the Observatory, is adorned with hanging holiday lights, wreaths, and an embellished Christmas tree. The iconic Fifth Avenue windows depict snowy scenes of Buddy the Elf and his friends as he travels from the North Pole to the “World’s Most Famous Building.” From Nov. 27 through Dec. 29, tenants and visitors who pass through the Fifth Avenue Lobby from Monday through Friday will hear festive holiday tunes performed by professional pianists.
Santa Claus is Comin’ to Town
On Dec. 2, 9, 11, 13, 16, 18, 20, and 22, Santa Claus himself will collect wish lists, spread holiday cheer, and pose for photos with Observatory guests in his own decorated corner on the 80th Floor. For more information on times, please visit esbnyc.com.
ESB Celebrates the 20th Anniversary of ‘Elf’
The beloved Christmas comedy features Buddy the Elf, who in the famous 2003 film travels to meet his father at his office in the Empire State Building. To celebrate the Christmas classic and the Empire State Building’s lead role in the film, ‘Elf’ will take over the Observatory with themed décor in the building’s Fifth Avenue windows and on the 86th Floor Observatory.
Fans can purchase a special ticket to view ‘Elf’ at one of four screenings on the Observatory’s 80th Floor on Sunday, Dec. 3, 10, 13 and 17. Tickets will include holiday-themed drinks and snacks, and full access to ESB’s second floor museum and 86th Floor Observatory. Tickets can be purchased here.
Baby It’s Cold Outside!
Nov. 23 through Jan. 7 from 10 a.m. to 8:00 p.m., S’mores N’more will pop up to sell their famed hot chocolate with oversized marshmallows to guests who purchase tickets to the 86th Floor Observation deck. Special flavors will include:
- “The Buddy” -- inspired by ‘Elf’, a classic hot chocolate with whipped cream, a pop tart marshmallow, M&Ms, chocolate, and a maple syrup drizzle
- “The King” -- inspired by “Kong” himself, a classic hot chocolate with whipped cream, a banana chocolate chip marshmallow, chocolate and banana poke sticks, and cocoa dust
- “Christmas in the Clouds,” a peppermint hot chocolate with whipped cream, a peppermint marshmallow, a York peppermint patty, and Christmas sprinkles
The Empire State Building’s world-famous outdoor Observatory is also equipped with heaters on the 86th Floor Observation Deck during the chillier months to provide guests with a comfortable viewing experience.
Holiday Lightings
The Empire State Building’s world-famous tower lights will shine throughout the holiday season with dedicated lightings for Thanksgiving, Chanukah, Christmas, and New Year’s Eve. The Empire State Building will also debut its annual holiday music-to-light show.
The Empire State Building’s world-famous Observatory Experience recently underwent a $165 million reimagination that features an interactive museum with nine galleries, brand-new host uniforms, and iconic Observatories on the 86th and 102nd floors. The Observatory Experience was recently named #1 attraction in the U.S. for the second consecutive year by TripAdvisor travelers. Text CONNECT to 274-16 to receive information about each Empire State Building tower lighting. More information about the Empire State Building can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust, Inc.
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231121955174/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
